Skip to content

Ayurvedic drug Navakarshika kashaya in gout (vatrakta)

Clinical evaluation of Navakarshika Kashaya in Vatarakta - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054355
Enrollment
30
Registered
2023-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

Sonam rawat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Sign and symptoms of Vatarakta Serum uric acid level more than 7mg/dl in male and 6mg/dl in female. Patients from age group 18-60 year Both previously treated and fresh cases will be taken.

Exclusion criteria

Exclusion criteria: 1.Patients with chronic systemic disorders which interferes with the present study. 2.Patients of age below 18 or more than 60 years. 3.Autoimmune diseases 4.Patients with osteoarthritis, tophaceous gouty arthritis. 5.Pregnancy 6.Patient with serious medical illness and psychiatric disorder.

Design outcomes

Primary

MeasureTime frame
Sandhi Shotha (swelling) Sandhi Ruka (pain) Daha (Burning sensation) Twak Vaivarnyata (Discoloration) Stabdhata (stiffness) Sandhi Vakrta ( Deformity) Timepoint: The assessment of patient will be done at interval of 15 days during the treatment

Secondary

MeasureTime frame
Serum uric acid Timepoint: The assessment of patient will be done at interval of 15 days during the treatment

Countries

India

Contacts

Public ContactSonam Rawat

Uttarakhand Ayurveda University

dineshdr157@gmail.com9411731180

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026